Bev McClure

1.8k total citations · 1 hit paper
27 papers, 1.3k citations indexed

About

Bev McClure is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bev McClure has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Surgery and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bev McClure's work include Colorectal and Anal Carcinomas (12 papers), Colorectal Cancer Surgical Treatments (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Bev McClure is often cited by papers focused on Colorectal and Anal Carcinomas (12 papers), Colorectal Cancer Surgical Treatments (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Bev McClure collaborates with scholars based in Australia, Canada and New Zealand. Bev McClure's co-authors include Richard Fisher, Bryan Burmeister, Samuel Y. Ngan, Stephen P. Ackland, John Mackay, Michael J. Solomon, John Zalcberg, Trevor Leong, Joseph McKendrick and David Schache and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and British Journal of Cancer.

In The Last Decade

Bev McClure

27 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

2012 585 citations Samuel Y. Ngan, Bryan Burmeister et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bev McClure Australia	11	891	745	289	153	150	27	1.3k
Lisa Zuraw Canada	10	682 0.8×	497 0.7×	613 2.1×	109 0.7×	200 1.3×	14	1.4k
R. Semrau Germany	23	493 0.6×	564 0.8×	478 1.7×	81 0.5×	408 2.7×	59	1.3k
Chi‐Leung Chiang Hong Kong	17	401 0.5×	203 0.3×	303 1.0×	123 0.8×	108 0.7×	88	971
Keith Unger United States	17	398 0.4×	275 0.4×	373 1.3×	169 1.1×	114 0.8×	64	940
Stella Y. Tsai Taiwan	19	471 0.5×	476 0.6×	373 1.3×	325 2.1×	423 2.8×	25	1.3k
Aroor R. Rao United States	14	616 0.7×	468 0.6×	446 1.5×	112 0.7×	101 0.7×	32	1.1k
Mian Xi China	23	503 0.6×	893 1.2×	837 2.9×	225 1.5×	67 0.4×	105	1.6k
Tyler P. Robin United States	17	608 0.7×	272 0.4×	405 1.4×	198 1.3×	169 1.1×	55	1.3k
James Jer‐Min Jian Taiwan	23	778 0.9×	842 1.1×	475 1.6×	375 2.5×	406 2.7×	32	1.9k
Jennifer A. Dorth United States	15	371 0.4×	248 0.3×	272 0.9×	76 0.5×	91 0.6×	60	837

Countries citing papers authored by Bev McClure

Since Specialization

Citations

This map shows the geographic impact of Bev McClure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bev McClure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bev McClure more than expected).

Fields of papers citing papers by Bev McClure

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bev McClure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bev McClure. The network helps show where Bev McClure may publish in the future.

Co-authorship network of co-authors of Bev McClure

This figure shows the co-authorship network connecting the top 25 collaborators of Bev McClure. A scholar is included among the top collaborators of Bev McClure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bev McClure. Bev McClure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

MacManus, Michael, Richard Fisher, Daniel Roos, et al.. (2018). Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03. Journal of Clinical Oncology. 36(29). 2918–2925. 66 indexed citations

MacManus, Michael, Richard Fisher, Daniel Roos, et al.. (2017). CVP OR R‐CVP GIVEN AFTER INVOLVED‐FIELD RADIOTHERAPY IMPROVES PROGRESSION FREE SURVIVAL IN STAGE I‐II FOLLICULAR LYMPHOMA: RESULTS OF AN INTERNATIONAL RANDOMIZED TRIAL. Hematological Oncology. 35(S2). 31–31. 4 indexed citations

McLachlan, Sue-Anne, Richard Fisher, John Zalcberg, et al.. (2016). The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04). European Journal of Cancer. 55. 15–26. 40 indexed citations

Ansari, Nabila, Michael J. Solomon, Richard Fisher, et al.. (2016). Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum. Annals of Surgery. 265(5). 882–888. 70 indexed citations

MacManus, Michael, Richard Fisher, Daniel Roos, et al.. (2016). Treatment with 6 Cycles of CVP or R-CVP after Involved Field Radiation Therapy (IFRT) Significantly Improves Progression-free Survival Compared to IFRT alone in Stage I-II Low Grade Follicular Lymphoma: Results of an International Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 96(5). 938–938. 3 indexed citations

Michael, Michael, Sarat Chander, J McKendrick, et al.. (2014). Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer. British Journal of Cancer. 111(10). 1924–1931. 5 indexed citations

Ngan, Samuel Y., Mathias Bressel, Bev McClure, et al.. (2014). A Phase II Trial of Integrated Preoperative Radiotherapy and Chemotherapy with Oxaliplatin 5-Fluorouracil and Folinic Acid in Patients with Locally Advanced Rectal Cancer: Trans-Tasman Radiation Oncology Group TROG 09.01. International Journal of Radiation Oncology*Biology*Physics. 90(1). S21–S22. 1 indexed citations

Ball, David, Richard Fisher, Bryan Burmeister, et al.. (2013). The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05). Radiotherapy and Oncology. 106(3). 305–311. 53 indexed citations

Ngan, Samuel Y., Bryan Burmeister, Richard Fisher, et al.. (2012). Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. Journal of Clinical Oncology. 30(31). 3827–3833. 585 indexed citations breakdown →

10.

Ngan, Samuel Y., Richard Fisher, Bryan Burmeister, et al.. (2012). Long-term Quality of Life in Patients Treated in TROG 01.04: A Randomized Trial Comparing Short Course and Long Course Preoperative Radiation Therapy for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 84(3). S143–S144. 8 indexed citations

11.

Rischin, Danny, Kailash Narayan, Amit M. Oza, et al.. (2010). Phase 1 Study of Tirapazamine in Combination With Radiation and Weekly Cisplatin in Patients With Locally Advanced Cervical Cancer. International Journal of Gynecological Cancer. 20(5). 827–833. 20 indexed citations

12.

Ngan, Samuel Y., R. Fisher, D. Goldstein, et al.. (2010). A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS).. Journal of Clinical Oncology. 28(15_suppl). 3509–3509. 42 indexed citations

13.

Ball, David, Richard A. Fisher, Bryan Burmeister, et al.. (2009). The complex relationship of lung tumor volume to survival in patients with non-small cell lung cancer (NSCLC) treated by definitive radiotherapy (RT): (Trans Tasman Radiation Oncology Group Study 9905). Journal of Thoracic Oncology. 4(9). 1 indexed citations

14.

Corry, June, Lester Peters, Richard Fisher, et al.. (2008). N2‐N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders—Results of Trans Tasman Radiation Oncology Group Study 98.02. Head & Neck. 30(6). 737–742. 86 indexed citations

15.

McLachlan, Sue Anne, Rebecca Fisher, Bev McClure, et al.. (2008). A comparison of quality of life in patients with T3 rectal cancer receiving short course versus long course preoperative radiation. A Trans-Tasman Radiation Oncology Group Trial (TROG 01.04). Journal of Clinical Oncology. 26(15_suppl). 4097–4097. 4 indexed citations

16.

Rischin, Danny, Amit M. Oza, Linda Mileshkin, et al.. (2007). A phase I study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer. Journal of Clinical Oncology. 25(18_suppl). 5543–5543. 3 indexed citations

17.

Ball, David, Richard Fisher, Bryan Burmeister, et al.. (2006). Stage Is Not a Reliable Indicator of Tumor Volume in Non-small Cell Lung Cancer: A Preliminary Analysis of the Trans-Tasman Radiation Oncology Group 99-05 Database. Journal of Thoracic Oncology. 1(7). 667–672. 24 indexed citations

18.

Jefford, Michael, Michael Michael, Mark Rosenthal, et al.. (2004). A Novel Combination of Cisplatin, Irinotecan, and Capecitabine in Patients with Advanced Cancer. Investigational New Drugs. 22(2). 185–192. 2 indexed citations

19.

Rischin, Danny, Lester Peters, Richard Fisher, et al.. (2004). Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). Journal of Clinical Oncology. 23(1). 79–87. 195 indexed citations

20.

Rischin, Danny, Michael Boyer, Judith Smith, et al.. (2000). A phase I trial of docetaxel and gemcitabine in patients with advanced cancer. Annals of Oncology. 11(4). 421–426. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact